RNA-guided nucleases and active fragments and variants thereof and methods of use
WO2025083619A9PCT designated stage expired Publication Date: 2026-06-04LIFEEDIT THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- LIFEEDIT THERAPEUTICS INC
- Filing Date
- 2024-10-17
- Publication Date
- 2026-06-04
Smart Images

Figure IB2024060233_04062026_PF_FP_ABST
Abstract
Compositions and methods for binding to a target sequence of interest are provided. The compositions find use in cleaving or modifying a target sequence of interest, visualization of a target sequence of interest, and modifying the expression of a sequence of interest. Compositions comprise RNA-guided nuclease (RGN) polypeptides, CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding the same. Vectors and host cells comprising the nucleic acid molecules are also provided. Further provided are RGN systems for binding a target sequence of interest, wherein the RGN system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs.
Need to check novelty before this filing date? Find Prior Art